[1]
“Protection of intestinal immune barrier against ischemia/reperfusion injury in a swine model using anisodamine hydrobromide”, Braz. J. Pharm. Sci., vol. 58, Dec. 2022, doi: 10.1590/s2175-97902022e20870.